Daito Pharmaceutical (China) Co., Ltd. is a joint venture in China established by Daito Pharmaceutical Co., Ltd. (headquartered in Toyama Prefecture, Japan) and Cheer Fine Pharmaceutical Co., Ltd. (Hong Kong). The Company is primarily engaged in the manufacture, sale, and import/export of pharmaceutical products...
Established in
2002
Registered capital
17 million US dollars
Employees
100
Nature of Business
Our business scope covers the entire pharmaceutical industry chain, including but not limited to:
Manufacturing and sales
Manufacturing and sales of pharmaceutical tablets, capsules, and other dosage forms for medical use.
R&D
Biotechnology R&D
Health food R&D
Research on modernized traditional Chinese medicine products
Technical consulting and services
Information consulting and technical services in life science and technology
Import and export business
Import and export business for self-operated and agency goods and technologies (except for those restricted or prohibited by the state).
Additional notes
Projects that require approval in accordance with the law may be carried out only after approval from the relevant authorities. (This is a general license statement and does not constitute part of the specific business scope classification.)
Product Center
The approved products fully demonstrate the Group's integrated industrial chain strategy of "Intermediates, APIs, and Formulations." The intermediates and API for Iguratimod Tablets, for example, are supplied by the Company's affiliated companies Cheer Fine Pharmaceutical (Anhui) and Anhui Tingworld Pharmaceutical, thereby ensuring supply chain stability and cost competitiveness.
Celecoxib Capsules
Anti-inflammatory and analgesic
Metformin Hydrochloride and Vildagliptin Tablets (II)
Type 2 diabetes mellitus
Corporate News
The latest updates on Daito Pharmaceutical (China) Co., Ltd. will be posted here. We welcome you to check back often.
Daito Pharmaceutical (China) Co., Ltd. Launches New Corporat
Daito Pharmaceutical (China) Co., Ltd. is a joint venture in China established b...
2026-07-08
Business & Development
As the Daito Group's formulation production base in China, the Company operates under a "dual-track" business model and has undergone two key phases of development.
Integration and Enhancement Phase (2012–present): Through systematic quality guidance, talent exchange programs, and management system development, the Company has comprehensively enhanced its production management capabilities and quality control standards. Building on this foundation, the Company has launched contract manufacturing services...
Daito Pharmaceutical (China) Co., Ltd. |
Mobile version
Copyright(C)2026, Daito Pharmaceutical (China) Co., Ltd. All Rights Reserved. Cheer Fine Pharmaceutical Tingworld Pharmaceutical Copyright Notice 备案序号:皖ICP备2026018112号